¼¼°èÀÇ °ü»óµ¿¸Æ¾Ð ½ÃÀå º¸°í¼­(2025³â)
Coronary Pressure Global Market Report 2025
»óǰÄÚµå : 1703236
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°ü»óµ¿¸Æ¾Ð ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 9.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 279¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ ÁßÀÇ ¼ºÀåÀº °ü»óµ¿¸ÆÁúȯ(CAD) À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, ºñ¿ë È¿À²ÀûÀÎ Ä¡·á¹ý Áõ°¡, ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»ó, ½ÅÁ¦Ç° ¹× ¼­ºñ½º Ãâ½Ã µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â °ü»óµ¿¸Æ¾Ð ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº °ü»óµ¿¸ÆÁúȯ, °íÇ÷¾Ð, ½ÉºÎÀü µî ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇϸç, »ýȰ½À°ü ¹× À¯ÀüÀû ¿äÀΰú °ü·ÃÀÌ ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡´Â °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, ÁÂ½Ä »ýȰ½À°ü, ºñ¸¸µµ Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. °ü»óµ¿¸Æ¾Ð ±â±â´Â °ü»óµ¿¸Æ¾ÐÀ» ÃøÁ¤Çϰí, Ä¡·á °áÁ¤À» À¯µµÇϰí, ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ »óŸ¦ Æò°¡ÇÏ°í °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 8¿ù Journal of the American College of Cardiology Àú³Î¿¡ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é 2025-2060³â »çÀÌ¿¡ ¹Ì±¹ Àα¸ÀÇ 4°¡Áö ½ÉÇ÷°ü À§Çè ¿äÀÎÀÌ ¸ðµÎ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¿¬±¸¿¡¼­´Â ´ç´¢º´ÀÌ 39.3%·Î °¡Àå ³ô¾Ò°í, ´ÙÀ½À¸·Î ÀÌ»óÁöÁúÇ÷Áõ(27.6%), °íÇ÷¾Ð(25.1%), ºñ¸¸(18.3%) Áõ°¡°¡ ¿¹ÃøµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½ÉºÎÀü(33.4%), ÇãÇ÷¼º ½ÉÀåÁúȯ(30.7%), ½É±Ù°æ»ö(16.9%), ³úÁ¹Áß(33.8%) Áõ°¡°¡ µÎµå·¯Áý´Ï´Ù. ÀÌ·¯ÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â °ü»óµ¿¸Æ¾Ð ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.

°ü»óµ¿¸Æ¾Ð ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Ä¡·á È¿°ú¸¦ ³ôÀ̰í ÀçÇùÂø·üÀ» ³·Ã߸ç ȯÀÚÀÇ Àå±â ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ¾àÁ¦¿ëÃâ °ü»óµ¿¸Æ ½ºÅÙÆ® ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ßÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ¾àÁ¦¿ëÃâ °ü»óµ¿¸Æ ½ºÅÙÆ® ½Ã½ºÅÛÀº ½ºÅÙÆ®¸¦ ÅëÇØ µ¿¸Æ¿¡ Á÷Á¢ ¾à¹°À» ¹æÃâÇÏ¿© °ü»óµ¿¸Æ ÁúȯÀ» Ä¡·áÇϴ Ư¼ö Àåºñ·Î, ÀçÇùÂø(µ¿¸Æ ÀçÇùÂø)ÀÇ À§ÇèÀ» °¨¼Ò½ÃÄÑ Àå±âÀûÀÎ Ç÷°ü °Ç°­À» ÁõÁø½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 5¿ù ¾ÆÀÏ·£µå¿¡ º»»ç¸¦ µÐ ÀÇ·á±â±â ȸ»ç MedtronicÀº Ãֽм¼´ëÀÇ ¿À´Ð½º ÇÁ·ÐƼ¾î ¾àÁ¦¿ëÃâ ½ºÅÙÆ®(Onyx Frontier drug-eluting stent)¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ÀÌ Ã·´Ü ½Ã½ºÅÛÀº ½ºÅÙÆ® »ðÀÔ ÈÄ ÀçÇùÂøÀ» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ¾à¹°À» Àü´ÞÇÏ¿© °ü»óµ¿¸Æ Áúȯ Ä¡·á¸¦ °­È­Çϵµ·Ï Á¶Á¤µÇ¾ú½À´Ï´Ù. ÀÌ »õ·Î¿î ½ºÅÙÆ® ½Ã½ºÅÛÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í °ü»óµ¿¸Æ ½Ã¼ú¿¡ µû¸¥ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϵµ·Ï ¼³°èµÈ ÷´Ü ±â¼úÀ» ÅëÇÕÇÑ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Coronary pressure is the pressure within the coronary arteries that deliver blood and oxygen to the heart muscle. This measure is vital for evaluating how well blood flow and oxygen are reaching the heart. Factors such as heart rate, blood volume, and arterial resistance affect coronary pressure, making its monitoring key for diagnosing and managing coronary artery disease.

Devices used to measure coronary pressure include sphygmomanometers, automated blood pressure monitors, blood pressure (BP) transducers, and ambulatory blood pressure monitors. A sphygmomanometer is used to manually measure blood pressure and usually features an inflatable cuff, a pressure gauge, and a bulb for inflation. These devices are available in digital, aneroid, and wearable forms and are utilized by various end users such as hospitals, cardiac care centers, ambulatory centers, homecare settings, and academic institutions.

The coronary pressure market research report is one of a series of new reports from The Business Research Company that provides coronary pressure market statistics, including coronary pressure industry global market size, regional shares, competitors with a coronary pressure market share, detailed coronary pressure market segments, market trends and opportunities, and any further data you may need to thrive in the coronary pressure industry. This coronary pressure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary pressure market size has grown rapidly in recent years. It will grow from $17.38 billion in 2024 to $19.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the rising incidence of cardiovascular diseases, increasing demand for coronary pressure monitoring, increasing awareness of heart health, and rising healthcare expenditure.

The coronary pressure market size is expected to see strong growth in the next few years. It will grow to $27.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the rising prevalence of coronary artery disease (CAD), the growing geriatric population, the increasing adoption of minimally invasive procedures, and increasing awareness about early disease detection. Major trends in the forecast period include technological advancements, increased cost-effective treatment, improved healthcare access, and launches of new products and services.

The rising prevalence of cardiovascular diseases is expected to drive growth in the coronary pressure market. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, which are often associated with lifestyle factors and genetics. The increase in cardiovascular disease rates is attributed to factors such as unhealthy diets, sedentary lifestyles, and rising obesity levels. Coronary pressure devices are essential for assessing and managing these conditions by measuring coronary artery pressures, guiding treatment decisions, and improving patient outcomes. For example, a study published in August 2022 in the Journal of the American College of Cardiology projected an increase in all four cardiovascular risk factors among the U.S. population from 2025 to 2060. The study highlighted diabetes with the highest projected increase at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). Additionally, significant increases were anticipated in heart failure (33.4%) and ischemic heart disease (30.7%), with heart attack (16.9%) and stroke (33.8%) also showing notable rises. This growing prevalence of cardiovascular diseases is a key driver of the coronary pressure market.

Leading companies in the coronary pressure market are prioritizing the development of innovative products, such as drug-eluting coronary stent systems, to boost treatment effectiveness, lower restenosis rates, and improve long-term patient outcomes. Drug-eluting coronary stent systems are specialized devices that address coronary artery disease by releasing medication directly into the artery through the stent, thereby reducing the risk of restenosis (artery re-narrowing) and promoting better long-term vascular health. For example, in May 2022, Medtronic, an Ireland-based medical device company, obtained FDA approval for its latest generation Onyx Frontier drug-eluting stent. This advanced system is tailored to enhance coronary artery disease treatment by delivering medications that help prevent restenosis after stent placement. The new stent system integrates advanced technology designed to improve patient outcomes and minimize complications associated with coronary procedures.

In May 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical technology company, acquired Shockwave Medical Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson's presence in the cardiovascular market, improve treatment options for patients, and support long-term financial growth. Shockwave Medical Inc., a US-based provider of coronary pressure devices, will contribute to Johnson & Johnson's expanded portfolio in this sector.

Major companies operating in the coronary pressure market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Philips Healthcare, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International

North America was the largest region in the coronary pressure market in 2024. The regions covered in the coronary pressure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary pressure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary pressure market consists of sales of fractional flow reserve (FFR) wire, instantaneous wave-free ratio (iFR) wire, pressure monitoring manifolds, and pressure measurement devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Pressure Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary pressure market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coronary pressure ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary pressure market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Coronary Pressure Market Characteristics

3. Coronary Pressure Market Trends And Strategies

4. Coronary Pressure Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coronary Pressure Growth Analysis And Strategic Analysis Framework

6. Coronary Pressure Market Segmentation

7. Coronary Pressure Market Regional And Country Analysis

8. Asia-Pacific Coronary Pressure Market

9. China Coronary Pressure Market

10. India Coronary Pressure Market

11. Japan Coronary Pressure Market

12. Australia Coronary Pressure Market

13. Indonesia Coronary Pressure Market

14. South Korea Coronary Pressure Market

15. Western Europe Coronary Pressure Market

16. UK Coronary Pressure Market

17. Germany Coronary Pressure Market

18. France Coronary Pressure Market

19. Italy Coronary Pressure Market

20. Spain Coronary Pressure Market

21. Eastern Europe Coronary Pressure Market

22. Russia Coronary Pressure Market

23. North America Coronary Pressure Market

24. USA Coronary Pressure Market

25. Canada Coronary Pressure Market

26. South America Coronary Pressure Market

27. Brazil Coronary Pressure Market

28. Middle East Coronary Pressure Market

29. Africa Coronary Pressure Market

30. Coronary Pressure Market Competitive Landscape And Company Profiles

31. Coronary Pressure Market Other Major And Innovative Companies

32. Global Coronary Pressure Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Pressure Market

34. Recent Developments In The Coronary Pressure Market

35. Coronary Pressure Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â